apomorphine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobylecki, C; Partington-Smith, L | 1 |
1 other study(ies) available for apomorphine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice.
Topics: Antiparkinson Agents; Apomorphine; COVID-19; Humans; Infusions, Subcutaneous; Pandemics; Parkinson Disease | 2023 |